Yestar Healthcare Holdings Company Limited released its Monthly Return for Equity Issuer for the period ended 31 August 2026, confirming that no changes occurred in either its authorised or issued share capital during the month.

Authorised / Registered Share Capital • Total authorised share capital stood unchanged at 4.00 billion ordinary shares with a par value of HKD 0.025 each, amounting to HKD 100.00 million.

Issued Share Capital and Treasury Shares • Issued shares (excluding treasury shares) remained at 2.33 billion, identical to the previous month. • The company held no treasury shares and reported no share repurchases or cancellations, leaving total issued shares unchanged at 2.33 billion.

Public Float Compliance • Yestar Healthcare confirmed full compliance with the Hong Kong Stock Exchange’s minimum public float requirement of 25% of issued share capital.

Capital Instruments and Corporate Actions • The company reported no outstanding share options, warrants, convertible securities, or other equity-linked instruments. • No new share issues, share repurchases, or redemptions were undertaken in August 2026.

Governance Confirmation • Director Qiao Jinrong certified that all regulatory and listing rule requirements were duly met during the reporting period.

The steady capital position underscores Yestar Healthcare’s unchanged equity structure and adherence to Hong Kong listing regulations throughout August 2026.